In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.

Monotherapy with a P2Y 12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI). In a ...

DUBLIN--(BUSINESS WIRE)--The "Global Percutaneous Coronary Intervention (PCI) Devices Market 2017-2021" report has been added to Research and Markets' offering. The global percutaneous coronary ...

Renee Y. Hsia ([email protected]), University of California San Francisco, San Francisco, California. Yu-Chu Shen, Naval Postgraduate School, Monterey, California; and National Bureau of Economic ...

WASHINGTON, DC — In a trial of patients undergoing PCI for acute ST-elevation MI (STEMI), a strategy of further PCI beyond the infarct-related artery guided by fractional flow reserve (FFR) ...

A statewide effort to get hospitals in Michigan to lower their procedural radiation levels for PCI resulted in a steady decrease over a 6-year period, new data show. “We were really pleased to see ...

DUBLIN, April 23, 2020 /PRNewswire/ -- The "China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market: Insights, Trends & Forecast (2020-2024)" report has been added to ...

According to results published in Catheterization and Cardiovascular Interventions, announcing endovascular equipment, implant and medication costs in the catheterization lab can significantly affect ...

DUBLIN--(BUSINESS WIRE)-- The " China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market: Insights, Trends & Forecast (2020-2024)" report has been added to ...